Global Research Status Regarding Uveitis in the Last Decade
PURPOSE: To provide an overview on global uveitis research in the last decade in terms of countries/regions, organizations, scholars, journals, trending topics, and fundings.
METHODS: This cross-sectional bibliometric analysis yielded 10656 uveitis publications in English for subsequent bibliometric analysis.
RESULTS: In terms of the number of publications, the leading country/region was the USA (3007). The most productive organization was the University College London (420). The most productive research team was Professor Yang's group (146). A higher h-index was noted in University College London (48). Professor Rosenbaum was the first h-index holder (32). Keywords of interest included topics such as biologics, COVID and OCT. Publications by Ocular Immunology and Inflammation (968) ranked the first position.
CONCLUSIONS: The USA is the leading force in uveitis study. Asian countries/regions, such as China (mainland) and India, are exerting a substantial role worldwide. Trendy topics cover COVID-19, OCTA.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:32 |
---|---|
Enthalten in: |
Ocular immunology and inflammation - 32(2024), 3 vom: 09. März, Seite 326-335 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Lu, Ao [VerfasserIn] |
---|
Links: |
---|
Themen: |
Bibliometric analysis |
---|
Anmerkungen: |
Date Completed 27.03.2024 Date Revised 27.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/09273948.2023.2170251 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM352086130 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM352086130 | ||
003 | DE-627 | ||
005 | 20240327235108.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/09273948.2023.2170251 |2 doi | |
028 | 5 | 2 | |a pubmed24n1350.xml |
035 | |a (DE-627)NLM352086130 | ||
035 | |a (NLM)36698094 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Lu, Ao |e verfasserin |4 aut | |
245 | 1 | 0 | |a Global Research Status Regarding Uveitis in the Last Decade |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 27.03.2024 | ||
500 | |a Date Revised 27.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a PURPOSE: To provide an overview on global uveitis research in the last decade in terms of countries/regions, organizations, scholars, journals, trending topics, and fundings | ||
520 | |a METHODS: This cross-sectional bibliometric analysis yielded 10656 uveitis publications in English for subsequent bibliometric analysis | ||
520 | |a RESULTS: In terms of the number of publications, the leading country/region was the USA (3007). The most productive organization was the University College London (420). The most productive research team was Professor Yang's group (146). A higher h-index was noted in University College London (48). Professor Rosenbaum was the first h-index holder (32). Keywords of interest included topics such as biologics, COVID and OCT. Publications by Ocular Immunology and Inflammation (968) ranked the first position | ||
520 | |a CONCLUSIONS: The USA is the leading force in uveitis study. Asian countries/regions, such as China (mainland) and India, are exerting a substantial role worldwide. Trendy topics cover COVID-19, OCTA | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Uveitis | |
650 | 4 | |a bibliometric analysis | |
650 | 4 | |a big data | |
650 | 4 | |a data mining | |
650 | 4 | |a scientific performance | |
700 | 1 | |a Liu, Zhangluxi |e verfasserin |4 aut | |
700 | 1 | |a Su, Guannan |e verfasserin |4 aut | |
700 | 1 | |a Yang, Peizeng |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Ocular immunology and inflammation |d 1993 |g 32(2024), 3 vom: 09. März, Seite 326-335 |w (DE-627)NLM091014069 |x 1744-5078 |7 nnns |
773 | 1 | 8 | |g volume:32 |g year:2024 |g number:3 |g day:09 |g month:03 |g pages:326-335 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/09273948.2023.2170251 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 32 |j 2024 |e 3 |b 09 |c 03 |h 326-335 |